CERo Therapeutics Holdings, Inc. (CERO) vs eFFECTOR Therapeutics, Inc. (EFTR)

CERo Therapeutics Holdings, Inc. and eFFECTOR Therapeutics, Inc. are both Biotechnology companies. eFFECTOR Therapeutics, Inc. is the larger, with a market value of $200.0K against $140.0K — 1.4× the size. eFFECTOR Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; CERo Therapeutics Holdings, Inc. trades at 0.0×. Across the 8 metrics below, eFFECTOR Therapeutics, Inc. leads on 5 and CERo Therapeutics Holdings, Inc. on 3.

Valuation

Metric CERO EFTR Biotechnology median
P/E 0.00 n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.20 0.74
EV/Sales n/m (1.67) 10.73
Earnings yield 300,221.00% 0.00% (28.84%)
Free cash flow yield (2,869.14%) 0.00% (23.03%)

Profitability

Metric CERO EFTR Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 453.76% 1,737.63% (57.72%)
Return on assets (2,352.32%) (141.18%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CERO EFTR Biotechnology median
Revenue growth (TTM) — (86.21%) 5.64%
EPS growth (last fiscal year) 92.12% (19.05%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CERO EFTR Biotechnology median
Debt to equity (0.02) 22.87 0.00
Current ratio 0.05 1.03 4.73
Net debt to EBITDA 0.10 (0.03) 0.96

Dividend

Metric CERO EFTR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CERO EFTR Biotechnology median
Market cap 140.00k 200.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack